File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial

TitleSafety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial
Authors
Issue Date2021
Citation
Nature Medicine, 2021, v. 27, p. 1725-1734 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/317821
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorYuen, RMF-
dc.contributor.authorHeo, J-
dc.contributor.authorJang, J-W-
dc.contributor.authorYoon, J-H-
dc.contributor.authorKweon, Y-O-
dc.contributor.authorPark, S-J-
dc.contributor.authorTami, Y-
dc.contributor.authorYou, S-
dc.contributor.authorYales, P-
dc.contributor.authorTao, Y-
dc.contributor.authorCremer, J-
dc.contributor.authorCampbell, F-
dc.contributor.authorElston, R-
dc.contributor.authorTheodore, D-
dc.contributor.authorPaff, M-
dc.contributor.authorBennett, CF-
dc.contributor.authorKwoh, TJ-
dc.date.accessioned2022-10-07T10:27:32Z-
dc.date.available2022-10-07T10:27:32Z-
dc.date.issued2021-
dc.identifier.citationNature Medicine, 2021, v. 27, p. 1725-1734-
dc.identifier.urihttp://hdl.handle.net/10722/317821-
dc.languageeng-
dc.relation.ispartofNature Medicine-
dc.titleSafety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial-
dc.typeArticle-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.authorityYuen, RMF=rp00479-
dc.identifier.doi10.1038/s41591-021-01513-4-
dc.identifier.hkuros336921-
dc.identifier.volume27-
dc.identifier.spage1725-
dc.identifier.epage1734-
dc.identifier.isiWOS:000706587600007-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats